Important new serological studies on the global hotspots New York City and England have been added to the international Covid IFR overview (section 1.B).
Unsurprisingly, they found rather high values. Two studies on NYC report values between 0.7% and 1.1% based on confirmed cases and up to 1.45% including probable cases. One study on England reports an IFR in the general population of 0.9% and of 1.43% including care homes.
Eine Übersicht aller bisher veröffentlichten Corona-Antikörperstudien in Deutschland.
Zur Übersicht →
Das Universitätsspital Zürich (USZ) hat Anfang August die Resultate seiner umfangreichen Antikörperstudie veröffentlicht. Die Antikörperwerte liegen im Kanton Zürich wie erwartet noch sehr tief. Bisher hat offenbar noch kein Medium über dieses sehr wichtige Resultat berichtet.
Weiterlesen →
To understand the dynamics of the Covid-19 pandemic in the USA, it is not sufficient to look at the aggregated figures at the national level. The US is not experiencing one single long wave, but several regional “short waves” that have been delayed by lockdowns or the spread of the virus itself.
See charts →
Das Schweizer Onlinemagazin “Republik” versucht in einem aktuellen Beitrag die Corona-Pandemie einzuordnen. Doch die Situation ist etwas komplexer.
Zum Beitrag →
The Italian health authority has published the very important results of its first nationwide coronavirus antibody study based on close to 65,000 participants.
Read more →
Please note: This is a recommendation to authorities and physicians. Patients are asked to consult a doctor.
SPR has updated its Covid-19 early treatment protocol and has added bromhexine. Bromhexine is a simple over-the-counter mucolytic cough medication that inhibits cellular TMPRSS2 protease and thus blocks SARS-CoV-2 cell entry via ACE2 cell receptors.
